Back to top
more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$605.09 USD

605.09
157,752

-10.60 (-1.72%)

Updated Aug 5, 2024 10:04 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $506.17, moving +0.63% from the previous trading session.

Thermo Fisher Scientific (TMO) Stock Moves -0.8%: What You Should Know

Thermo Fisher Scientific (TMO) closed at $501.59 in the latest trading session, marking a -0.8% move from the prior day.

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Sector ETF report for IHI

Thermo Fisher Scientific (TMO) Stock Moves -0.76%: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $504.89, moving -0.76% from the previous trading session.

Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know

Thermo Fisher Scientific (TMO) closed at $507.73 in the latest trading session, marking a -1.51% move from the prior day.

Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $510.99, marking a -0.77% move from the previous day.

Thermo Fisher (TMO) to Advance Clinical Research With New Pact

Thermo Fisher's clinical research division will aid in increasing community health clinics' capacity to participate in clinical studies.

Thermo Fisher (TMO) Adds New Platform to CTS Product Portfolio

Thermo Fisher (TMO) launches the next-generation Gibco CTS Detachable Dynabeads platform.

Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

Thermo Fisher Scientific (TMO) closed at $536.70 in the latest trading session, marking a -0.98% move from the prior day.

Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Thermo Fisher Scientific (TMO) closed at $557.10, marking a -0.34% move from the previous day.

Steris (STE) Up 1.8% Since Last Earnings Report: Can It Continue?

Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Is Thermo Fisher (TMO) Down 3.9% Since Last Earnings Report?

Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Thermo Fisher's (TMO) EXTENT Solution Makes Commercial Launch

Thermo Fisher (TMO) announces the commercial launch of the EXTENT Solution with IVDR certification.

Thermo Fisher (TMO) Launches New Chromosomal Microarray

Thermo Fisher's (TMO) CytoScan HD Accel array can save labs weeks or even months by accelerating the time it takes to get findings from cytogenetic research.

Thermo Fisher (TMO) Business Hurt by Low COVID Sales, FX Woe

Thermo Fisher (TMO) is witnessing headwinds in the government and academic end markets.

Thermo Fisher (TMO) Completes the CorEvitas Acquisition

Thermo Fisher's (TMO) latest buyout is likely to deliver $0.03 in adjusted earnings per share in 2024 and be marginally accretive in 2023.

Accuray's (ARAY) Treatment Options to be Boosted Post FDA's Nod

Accuray's (ARAY) latest regulatory approval is likely to improve breast cancer treatment.

Thermo Fisher (TMO) Q2 Earnings Miss Estimates, Margins Down

Challenging macroeconomic conditions and slowdown in activities in China impede Thermo Fisher's (TMO) Q2 revenues.

Thermo Fisher (TMO) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Thermo Fisher (TMO) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Thermo Fisher Scientific (TMO) Lags Q2 Earnings and Revenue Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of -5.16% and 2.77%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

MedTech Stocks' Q2 Earnings Due on Jul 26: DGX, TMO and More

MedTech companies' second-quarter results are likely to reflect a year-over-year decline. Let's see how DGX, TMO, EW and ALGN fare this time.

Earnings Preview: Teleflex (TFX) Q2 Earnings Expected to Decline

Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thermo Fisher Scientific (TMO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know

Thermo Fisher Scientific (TMO) closed the most recent trading day at $523.68, moving -0.3% from the previous trading session.